| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.02B | +8.0% |
| Cost of Revenue | $1.91B | +7.4% |
| Gross Profit | $1.11B | +9.1% |
| R&D Expense | $186.2M | -2.4% |
| SG&A Expense | $526.8M | +10.6% |
| Operating Income | $394.1M | +58.1% |
| Pre-tax Income | $139.2M | +353.0% |
| Income Tax | $11.3M | -40.2% |
| Net Income | $72.1M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $282.0M | +155.1% |
| Inventory | $606.3M | -1.0% |
| Current Assets | $1.91B | +20.4% |
| Total Assets | $3.68B | +5.1% |
| Current Liabilities | $881.6M | -22.0% |
| Long-term Debt | $2.57B | +7.8% |
| Stockholders' Equity | -$70.8M | +35.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $340.0M | +15.2% |
| Capital Expenditures | $70.1M | +34.9% |
| Investing Cash Flow | -$112.3M | -78.2% |
| Financing Cash Flow | -$31.5M | +85.1% |
| Free Cash Flow | $269.9M | +11.0% |
| +161.6% |
| EPS (Basic) | $0.23 | +160.5% |
| EPS (Diluted) | $0.22 | +157.9% |